Neurogene

A cancer biotech’s collapse gives Neurogene a path to Wall Street
BioPharma Dive
Tue, 07/18/23 - 10:01 pm
Neurogene
gene therapy
reverse merger
Neoleukin
Neurogene Launches With $68.5 Million to Advance Gene Therapies for Rare Neurological Diseases
BioSpace
Tue, 02/12/19 - 12:07 pm
Neurogene
gene therapy
neurological disorders